Robertson Stephens Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Robertson Stephens Wealth Management's NVS Position: Q2 2026 in Review
Robertson Stephens Wealth Management reduced its Novartis (NVS) stake by 0.87% in Q2 2026, selling an estimated $3.9K and leaving 2,962 shares worth $464K. The position accounts for 0.01% of the portfolio, ranked #454.
Robertson Stephens Wealth Management first reported a position in NVS in Q1 2021 and has held it in 19 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Robertson Stephens Wealth Management held 2,962 shares of Novartis worth $464K as of Q2 2026.
- Robertson Stephens Wealth Management sold 26 Novartis shares in Q2 2026, an estimated $3.9K.
- Novartis made up 0.01% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #454 holding.
- Robertson Stephens Wealth Management first reported a position in Novartis in Q1 2021 and has held it in 19 quarters since.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.